BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36903369)

  • 1. LncRNA-MALAT1: A Key Participant in the Occurrence and Development of Cancer.
    Hao L; Wu W; Xu Y; Chen Y; Meng C; Yun J; Wang X
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
    Pang EJ; Yang R; Fu XB; Liu YF
    Tumour Biol; 2015 Apr; 36(4):2403-7. PubMed ID: 25481511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple function of lncRNA MALAT1 in cancer occurrence and progression.
    Malakoti F; Targhazeh N; Karimzadeh H; Mohammadi E; Asadi M; Asemi Z; Alemi F
    Chem Biol Drug Des; 2023 May; 101(5):1113-1137. PubMed ID: 34918470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway.
    Li Y; Liu YD; Chen SL; Chen X; Ye DS; Zhou XY; Zhe J; Zhang J
    Mol Hum Reprod; 2019 Jan; 25(1):17-29. PubMed ID: 30371869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALAT1 in colorectal cancer: Its implication as a diagnostic, prognostic, and predictive biomarker.
    Cervena K; Vodenkova S; Vymetalkova V
    Gene; 2022 Nov; 843():146791. PubMed ID: 35961438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression.
    Su K; Wang N; Shao Q; Liu H; Zhao B; Ma S
    Biomed Pharmacother; 2021 May; 137():111389. PubMed ID: 33601150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA MALAT1-related signaling pathways in osteosarcoma.
    Farzaneh M; Najafi S; Anbiyaee O; Azizidoost S; Khoshnam SE
    Clin Transl Oncol; 2023 Jan; 25(1):21-32. PubMed ID: 35790599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
    Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
    Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Noncoding RNA MALAT1: Insights into its Biogenesis and Implications in Human Disease.
    Wu Y; Huang C; Meng X; Li J
    Curr Pharm Des; 2015; 21(34):5017-28. PubMed ID: 26205289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oct4 transcriptionally regulates the expression of long non-coding RNAs NEAT1 and MALAT1 to promote lung cancer progression.
    Jen J; Tang YA; Lu YH; Lin CC; Lai WW; Wang YC
    Mol Cancer; 2017 Jun; 16(1):104. PubMed ID: 28615056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
    Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
    Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
    Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
    Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis.
    Ghafouri-Fard S; Ashrafi Hafez A; Taheri M
    Exp Mol Pathol; 2020 Feb; 112():104330. PubMed ID: 31712117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long noncoding RNA Malat1: Its physiological and pathophysiological functions.
    Zhang X; Hamblin MH; Yin KJ
    RNA Biol; 2017 Dec; 14(12):1705-1714. PubMed ID: 28837398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway.
    Jin Y; Feng SJ; Qiu S; Shao N; Zheng JH
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3176-3184. PubMed ID: 28770968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs: From disease code to drug role.
    Chen Y; Li Z; Chen X; Zhang S
    Acta Pharm Sin B; 2021 Feb; 11(2):340-354. PubMed ID: 33643816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of long non-coding RNA MALAT1 suppresses inflammation in septic mice: role of microRNA-23a in the down-regulation of MCEMP1 expression.
    Xie W; Chen L; Chen L; Kou Q
    Inflamm Res; 2020 Feb; 69(2):179-190. PubMed ID: 31893303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between long non-coding RNA MALAT1 and prostate cancer].
    Zhang F; Wu CF; Luo YH; Zhou FH
    Zhonghua Nan Ke Xue; 2020 Feb; 26(2):174-179. PubMed ID: 33346423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MALAT1 -- a paradigm for long noncoding RNA function in cancer.
    Gutschner T; Hämmerle M; Diederichs S
    J Mol Med (Berl); 2013 Jul; 91(7):791-801. PubMed ID: 23529762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MALAT1 promotes development of mantle cell lymphoma by associating with EZH2.
    Wang X; Sehgal L; Jain N; Khashab T; Mathur R; Samaniego F
    J Transl Med; 2016 Dec; 14(1):346. PubMed ID: 27998273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.